Concurrent chemoradiotherapy by simultaneously integrated boost volumetric-modulated arc therapy for nasopharyngeal carcinoma-toxicity/quality of life and survival.
Fu-Min FangTai-Lin HuangYun-Hsuan LinChih-Yen ChienHui-Ching ChuangSheng-Dean LuoHsin-Ching LinYu-Tsai LinShau-Hsuan LiKuan-Cho LiaoWen-Ling TsaiPublished in: Head & neck (2018)
CCRT with SIB-VMAT produces excellent locoregional control, few severe late toxicity, and good general health status for NPC patients.